Unexpected response to fourth-line paclitaxel in a patient with metastatic oropharyngeal squamous cell carcinoma, immunotherapy-refractory: a case report.

Mosca, Mirta; Filippini, Daria Maria; Tober, Nastassja; Rojas, Fabiola Lorena; Rihawi, Karim; Di Fabio, Francesca

Mosca, Mirta; Filippini, Daria Maria; Tober, Nastassja; Rojas, Fabiola Lorena; Rihawi, Karim; Di Fabio, Francesca.

Afiliación

Mosca M; Department of Experimental, Diagnostic and Specialty Medicine, Policlinico di Sant'Orsola University Hospital.
Filippini DM; Department of Experimental, Diagnostic and Specialty Medicine, Policlinico di Sant'Orsola University Hospital.
Tober N; Division of Medical Oncology, Department of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Rojas FL; Department of Experimental, Diagnostic and Specialty Medicine, Policlinico di Sant'Orsola University Hospital.
Rihawi K; Department of Experimental, Diagnostic and Specialty Medicine, Policlinico di Sant'Orsola University Hospital.
Di Fabio F; Division of Medical Oncology, Department of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Anticancer Drugs ; 33(7): 691-695, 2022 08 01.

Article en En | MEDLINE | ID: mdl-35324531

Asunto(s)

Neoplasias de Cabeza y Cuello; Nivolumab; Neoplasias de Cabeza y Cuello/tratamiento farmacológico; Humanos; Inmunoterapia/métodos; Recurrencia Local de Neoplasia/terapia; Nivolumab/uso terapéutico; Paclitaxel; Calidad de Vida; Carcinoma de Células Escamosas de Cabeza y Cuello/tratamiento farmacológico; Microambiente Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Neoplasias de Cabeza y Cuello Límite: Humans Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google